Skip to content
Find an ETF
← All ETFs

Available in 10 markets

UBS SPI® Extra ETF CHF acc

UBS · CH1553162921

UBS SPI® Extra ETF CHF acc is an exchange-traded fund (ETF) from UBS, traded under the ticker SPIEXT (ISIN CH1553162921). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. In plain terms it is about owning small slices of companies, so you share in their growth when they…

Equity ?Accumulating ?Physical ?Switzerland ?
Low yearly feeReinvests dividendsOwns the shares directlyOtherConcentrated in a few names
Fund size (AUM) ?
€9.8M
Yearly fee (TER) ?
0.13%
All-in cost ≈ 0.00%

About this fund

What you own

By holding it, this fund gives you a stake in around 10 companies across Other in a single purchase.

Dividends

The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.

Read more

Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.

How it works

The fund actually buys every share in the index it tracks (full replication).

Read more

Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.

Cost

0.13%Yearly fee (TER)
0.00%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Replication ?
Physical
Full — buys every share
Launched
2026

Performance

97.498.198.899.5100202620262026

Growth of CHF100 invested — the line starts at CHF100.

UBS SPI® Extra ETF CHF acc

End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.

The bigger picture

-0.4%
Since inception
Total growth since the fund launched.

What's inside

By sector ?

Cash/Other56.7%
Health Care18.8%
Industrials10.9%
Financials7.4%
Materials3.7%
Real Estate2.5%

The 10 biggest holdings make up 42.8% of the fund.

Top 10 holdings

#CompanyWeight
1GALDERMA GROUP AG7.9%
2SANDOZ GROUP AG7.0%
3VAT GROUP AG4.3%
4HELVETIA BALOISE HOLDING AG4.0%
5SGS SA-REG4.0%
6DSM-FIRMENICH AG3.9%
7JULIUS BAER GROUP LTD3.7%
8STRAUMANN HOLDING AG-REG2.8%
9SCHINDLER HOLDING-PART CERT2.6%
10SWISS PRIME SITE-REG2.6%

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
SIXSPIEXTCHF★ Primary
CHF listings
E1SPIEXCHFCHF
EOSPIEXCHFCHF
EPSPIEXCHFCHF
EUSPIEXCHFCHF
EZSPIEXCHFCHF
S1SPIEXZCHF
SESPIEXTCHF
X1SPIEXCHFCHF
X2SPIEXCHFCHF
XASPIEXCHFCHF
XFSPIEXCHFCHF
XGSPIEXCHFCHF
XHSPIEXCHFCHF
XJSPIEXCHFCHF
XLSPIEXCHFCHF
XOSPIEXCHFCHF
XQSPIEXCHFCHF
XUSPIEXCHFCHF
XVSPIEXCHFCHF
XWSPIEXCHFCHF
XXSPIEXCHFCHF
XYSPIEXCHFCHF
XZSPIEXCHFCHF
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

How it ranks vs peers

🪙 Cheaper than 76% of similar ETFs

Versus the Equity (stocks) · Other · CHF ETFs we track.

Advanced risk

CHF 13.33
52-week high ?
CHF 13.01
52-week low ?

Tilt vs a world tracker

United States-72.1
Cash/Other+56.7
Cash/Other+56.7
Switzerland+41.0
Technology-29.2
Health Care+9.5

Percentage points over / under a broad world-equity tracker (not a licensed benchmark).

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 Other stocks
Compare side by side
6 similar funds
UBS SPI® Extra ETF CHF accUBSYou're viewingState Street® Technology Select Sector SPDR® ETFSPDRBroader matchSchwab International Equity ETFSchwabBroader matchInvesco S&P 500 UCITS ETF AccInvescoBroader matchState Street® Financial Select Sector SPDR® ETFSPDRBroader matchState Street® SPDR® S&P® 500 MXN Hdg UCITS ETF (Acc)SPDRBroader matchState Street® SPDR® S&P® 500 GBP Hdg UCITS ETF (Dist)SPDRBroader match
Why it's similarThis is the fund on this page.
StocksPhysicalCheaper fee
StocksPhysicalCheaper fee
StocksAccumulatingCheaper fee
Copies the index with a swap, not by holding the shares.
StocksPhysicalCheaper fee
StocksAccumulatingPhysicalCheaper fee
StocksPhysicalCheaper fee
Index trackedTechnology Select Sector IndexFTSE Developed ex US IndexS&P 500® Total Return (Net) IndexFinancial Select Sector Index® ® S&p® 500 Mxn Hdg® ® S&p® 500 Hdg
Yearly fee (TER)0.13%0.08%0.03%0.05%0.08%0.05%0.05%
All-in cost0.00%0.00%0.00%0.12%0.00%0.06%0.06%
Fund size€9.8M€100.7B€57.6B€50.3B€48.9B€36.7B€36.7B
DomicileSwitzerlandUnited StatesUnited StatesIrelandUnited StatesIrelandIreland
ReplicationPhysical (full)Physical (full)Physical (full)Synthetic (swap)Physical (full)Physical (full)Physical (full)
3-yr return p.a.+26.5%+13.9%-73.9%+16.7%
5-yr return p.a.+18.6%+6.7%+9.2%
# holdings10771,49457280505505

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-07-21 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.